Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ausems

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
American Journal of Human Genetics|October 27, 2009
Identification of CANT1 mutations in Desbuquois dysplasiaCéline Huber, Bénédicte Oulès, Marta Bertoli, et al.
Clinical Genetics|February 27, 2010
Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distressC R M Lammens, E M A Bleiker, S Verhoef, et al.
Journal of Medical Genetics|September 6, 2005
Cancer risks in BRCA2 families: estimates for sites other than breast and ovaryC J van Asperen, R M Brohet, E J Meijers-Heijboer, et al.
BMC Cancer|October 4, 2012
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trialSepideh Saadatmand, Emiel J T Rutgers, Rob A E M Tollenaar, et al.
BMJ Open|October 9, 2024
Cohort profile: a nationwide study in Dutch <i>CHEK2</i> c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2Maartje A C Schreurs, Muriel A Adank, Antoinette Hollestelle, et al.
International Journal of Cancer|June 21, 2014
Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysisBernadette A M Heemskerk-Gerritsen, Matti A Rookus, Cora M Aalfs, et al.
Gastroenterology|June 15, 2015
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1Rachel S van der Post, Ingrid P Vogelaar, Peggy Manders, et al.
Breast Cancer Research and Treatment|May 4, 2022
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort studyMark van Barele, Amy Rieborn, Bernadette A M Heemskerk-Gerritsen, et al.
Brain Communications|March 30, 2022
Transactive response DNA-binding protein-43 proteinopathy in oligodendrocytes revealed using an induced pluripotent stem cell modelSamantha K Barton, Dario Magnani, Owen G James, et al.
Human Reproduction (Oxford, England)|December 2, 2016
Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?Theodora C van Tilborg, Inge A P Derks-Smeets, Anna M E Bos, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
American Journal of Human Genetics|October 27, 2009
Identification of CANT1 mutations in Desbuquois dysplasiaCéline Huber, Bénédicte Oulès, Marta Bertoli, et al.
Clinical Genetics|February 27, 2010
Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distressC R M Lammens, E M A Bleiker, S Verhoef, et al.
Journal of Medical Genetics|September 6, 2005
Cancer risks in BRCA2 families: estimates for sites other than breast and ovaryC J van Asperen, R M Brohet, E J Meijers-Heijboer, et al.
BMC Cancer|October 4, 2012
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trialSepideh Saadatmand, Emiel J T Rutgers, Rob A E M Tollenaar, et al.
BMJ Open|October 9, 2024
Cohort profile: a nationwide study in Dutch <i>CHEK2</i> c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2Maartje A C Schreurs, Muriel A Adank, Antoinette Hollestelle, et al.
International Journal of Cancer|June 21, 2014
Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysisBernadette A M Heemskerk-Gerritsen, Matti A Rookus, Cora M Aalfs, et al.
Gastroenterology|June 15, 2015
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1Rachel S van der Post, Ingrid P Vogelaar, Peggy Manders, et al.
Breast Cancer Research and Treatment|May 4, 2022
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort studyMark van Barele, Amy Rieborn, Bernadette A M Heemskerk-Gerritsen, et al.
Brain Communications|March 30, 2022
Transactive response DNA-binding protein-43 proteinopathy in oligodendrocytes revealed using an induced pluripotent stem cell modelSamantha K Barton, Dario Magnani, Owen G James, et al.
Human Reproduction (Oxford, England)|December 2, 2016
Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?Theodora C van Tilborg, Inge A P Derks-Smeets, Anna M E Bos, et al.
Pageof 21